Orgenesis Inc. (NasdaqCM:ORGS) agreed to acquire 25% stake in Octomera LLC from MM OS Holdings, L.P. on January 31, 2024. In exchange, MM OS Holdings shall receive a royalty of 5% of the net revenue of Octomera?s cell processing services, for the three calendar years 2025-2027
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 USD | -9.56% | -8.72% | -6.13% |
May. 20 | Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-6.13% | 16.18M | |
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
+16.92% | 25.62B | |
-6.87% | 23.32B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. agreed to acquire 25% stake in Octomera LLC from MM OS Holdings, L.P.